Login / Signup

Assessing the validity of plasma phospholipid fatty acids as biomarkers of dairy fat intake using data from a randomized controlled intervention trial.

Hilary J BethancourtKelsey A SchmidtGail CromerMaggie S BurhansJessica N KuzmaDerek K HagmanImashi FernandoMerideth MurrayKristina M UtzschneiderSarah E HolteRoss L PrenticeJana KraftMario Kratz
Published in: The American journal of clinical nutrition (2022)
The potential for liver fat to affect relative plasma phospholipid concentrations of C15:0 and C17:0 raises questions about their validity as biomarkers of dairy fat intake. Of the fatty acid measures tested, trans-C16:1n-7 combined with iso-C17:0, especially with adjustment of liver fat, age, and sex, may provide the most robust estimate of dairy fat consumption.
Keyphrases
  • fatty acid
  • adipose tissue
  • randomized controlled trial
  • risk assessment
  • physical activity
  • electronic health record
  • body mass index
  • phase iii
  • open label
  • phase ii